Malaysian Startup Eyes Commercialization of LabGrown Unagi Cooper Companies Stock Wall Street Analysts Weigh In on Price Targets Freedom Broker Upgrades Realty Income O to Buy Following Strong Q1 AFFO Performance Tariffs Ease but Trust Gap Persists for Chinese Companies in US Market Global Ship Lease Reports First Quarter 2026 Results Management Discusses Market Conditions and Fleet Utilization IEA Report Global Electric Car Sales Surpass 20 Million in 2025 Signaling Shift in Energy Landscape Unitil Corporation UTL Q1 2026 Earnings Modest EPS Beat Stock Edges Higher RNTX Q1 2026 Earnings EPS Beats Estimates as Preclinical Stage Biotech Tightens Spending WLTH Q1 2026 Earnings EPS Miss Widens as Costs Outpace Estimates Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises STRL Q1 2026 Earnings EPS Surges Past Estimates on Strong Execution FCRX Q1 2026 Earnings Slight EPS Miss Reflects Stable but Unspectacular Quarter Zillow Faces Headwinds as Shares Decline Over 1 Key Levels to Watch Oracle Corporation ORCL Hovers Near Resistance Amid Modest Decline Mustang Bio MBIO Edges Higher Biotech Stock Testing Key Resistance at 067 Kalaris Therapeutics KLRS Posts Modest Gain Holding Above Key Support Lionheart Holdings CUB Consolidates at 1080 Key Levels Define the Next Move MindWalk Holdings Corp HYFT Climbs 468 Testing Key Resistance at 188 Orla Mining ORLA Dips Over 2 as Resistance Holds Firm SR Bancorp SRBK Holds Steady Near Support Amid Low Volume M3Brigade Acquisition V Corp MBAV Holds Steady Near 1080 as SPAC Market Awaits Catalyst Woodside Energy WDS Holds Steady Near 2175 Amid Mixed Energy Sector Sentiment Gogoro Inc GGR Shows Modest Decline Amid Consolidation Wheat Futures Retreat on Friday as Rally Pauses OTEX Q1 2026 Earnings EPS Beats Estimates by 746 Shares Dip RH RH Rallies 245 as Shares Test Resistance Near 149 TaskUs Q1 2026 Earnings EPS Slightly Misses Estimates Stock Rises FGBIP Q1 2026 Earnings EPS Surges 96 Above Estimates Stock Edges Lower EXK Q1 2026 Earnings EPS Smashes Estimates by Nearly 60 Stock Edges Lower ASR Q1 2026 Earnings EPS Misses Estimates as Operational Challenges Weigh Cytek Biosciences Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment FET Q1 2026 Earnings EPS Surprises to the Upside as Stock Pulls Back HMY Q2 2016 Earnings Earnings Miss Highlights Operational Headwinds